BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$629M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$380M |
| 3 |
Apple
AAPL
|
+$369M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$226M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$161M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.69B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$893M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$361M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$321M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$148M |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 9.47% |
| 4 | Financials | 9.13% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Arbutus Biopharma
ABUS
$939M
| $64.6K | ﹤0.01% |
23,836
+16,093
| +208% | +$43.6K |
|
2677
Northeast Bank
NBN
$946M
| $64.3K | ﹤0.01% |
1,761
+1,662
| +1,679% | +$60.7K |
|
2678
ACNB Corp
ACNB
$473M
| $64.2K | ﹤0.01% |
2,162
+2,149
| +16,531% | +$63.8K |
|
2679
Citizens
CIA
$273M
| $64.2K | ﹤0.01% |
15,316
+7,086
| +86% | +$29.7K |
|
2680
Red River Bancshares
RRBI
$435M
| $64.1K | ﹤0.01% |
1,186
-74
| -6% | -$4K |
|
2681
iShares Select Dividend ETF
DVY
$20.9B
| $64.1K | ﹤0.01% |
545
+462
| +557% | +$54.4K |
|
2682
Park-Ohio Holdings
PKOH
$319M
| $63.9K | ﹤0.01% |
4,027
+161
| +4% | +$2.55K |
|
2683
Vanguard Value ETF
VTV
$146B
| $63.8K | ﹤0.01% |
484
-1,927
| -80% | -$254K |
|
2684
Allient
ALNT
$788M
| $63.7K | ﹤0.01% |
2,791
+1,747
| +167% | +$39.9K |
|
2685
Home Bancorp
HBCP
$441M
| $63.3K | ﹤0.01% |
1,855
+11
| +0.6% | +$375 |
|
2686
Tiptree Inc
TIPT
$925M
| $63.1K | ﹤0.01% |
5,937
-686
| -10% | -$7.29K |
|
2687
Cato Corp
CATO
$90M
| $62.7K | ﹤0.01% |
5,402
-867
| -14% | -$10.1K |
|
2688
Oil-Dri
ODC
$970M
| $62.6K | ﹤0.01% |
4,086
-2,418
| -37% | -$37.1K |
|
2689
Colony Bankcorp
CBAN
$305M
| $62.4K | ﹤0.01% |
+4,137
| New | +$62.4K |
|
2690
AllianceBernstein
AB
$4.24B
| $62.2K | ﹤0.01% |
1,496
-67,603
| -98% | -$2.81M |
|
2691
UroGen Pharma
URGN
$891M
| $62.1K | ﹤0.01% |
7,580
+5,881
| +346% | +$48.2K |
|
|
RSX
2692
DELISTED
VanEck Russia ETF
RSX
| $61.5K | ﹤0.01% |
10,888
| – | – |
|
2693
Duluth Holdings
DLTH
$133M
| $61.3K | ﹤0.01% |
6,422
+4,742
| +282% | +$45.2K |
|
|
PRTK
2694
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $60.8K | ﹤0.01% |
31,480
-9,444
| -23% | -$18.2K |
|
2695
Alico
ALCO
$261M
| $60.6K | ﹤0.01% |
1,700
+1,594
| +1,504% | +$56.8K |
|
2696
Gladstone Capital
GLAD
$527M
| $60.3K | ﹤0.01% |
2,988
+838
| +39% | +$16.9K |
|
2697
OraSure Technologies
OSUR
$243M
| $60.1K | ﹤0.01% |
22,169
-1,045
| -5% | -$2.83K |
|
2698
Aspen Aerogels
ASPN
$560M
| $60K | ﹤0.01% |
6,068
+4,072
| +204% | +$40.2K |
|
|
PZN
2699
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $59.4K | ﹤0.01% |
9,008
+3,518
| +64% | +$23.2K |
|
2700
Rocky Brands
RCKY
$220M
| $59.3K | ﹤0.01% |
1,736
-185
| -10% | -$6.32K |
|